Overview
- Brady announced on Jan. 12 via social media that he is taking the founding Chief Wellness Officer role at eMed.
- He will serve on eMed’s board with a focus on raising awareness for medically supervised GLP-1 treatment pathways.
- eMed describes its offering as making GLP-1 access and care “simple, supportive and individualized” through a structured program.
- The company, which gained visibility with at-home COVID-19 testing, has pivoted to employer-focused solutions addressing rising weight-loss drug costs.
- Brady continues in other public roles, including Fox NFL commentary and a minority stake in the Raiders, whose 3–14 season has fueled outside scrutiny of team direction.